The New York Office of Cannabis Management held a Control Board Meeting today that was broadcast online. Earlier this month, it published an annual report for FY2024, which ended...
RIV Capital Settles Application Initiated by JW Asset Management TORONTO, Feb. 23, 2023 /PRNewswire/ – RIV Capital Inc. (“RIV Capital” or the “Company”) (CSE: RIV) (OTC: CNPOF), an acquisition...
Exclusive Interview with RIV Capital President and CEO Mark Sims RIV Capital (CSE: RIV) (OTC: CNPOF) has evolved significantly since its inception. The company began as Canopy Rivers, the...
TORONTO, April 22, 2022 /PRNewswire/ – RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) (“RIV Capital” or the “Company”) today announced completion of the initial closing (the “Initial Closing”) of its previously...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
RIV Capital to acquire New York-based Etain, names new CEO to lead entry and expansion in U.S. cannabis market Transformative transaction will include one of only 10 vertically integrated...
New York’s medical cannabis program has developed substantially over the past several years and is now dominated by publicly traded companies. While it appeared that 2019 would be the...
Following up from its August 10th news release, the New York State Department of Health has published proposed regulations to the New York State Register today that detail some...
With New York on the verge of adding five additional license holders, four of the five existing operators in the state’s medical cannabis program have filed a suit against...
New York’s medical cannabis program, which has allowed its five licensed producers to sell the medicine only in extracted form and not flower since its launch in at the...
The New York medical cannabis program, which first welcomed patients in January, has gotten off to an extremely slow start, yet the state is contemplating expanding the number of...
Politico is reporting that the 5 licensed medical cannabis companies in New York have formed the Medical Cannabis Industry Association. The 5 companies include Vireo Health, Bloomfield Industries, Columbia...
When New York awarded five licenses to manufacture and sell medical cannabis extracts in July, one of the big questions was the ability of the companies to have product...
Etain, one of the five companies awarded a medical cannabis license by New York State in late July, is a women-owned business operated by Amy Peckham, CEO, and her...
Despite the tight window following the July approvals for the five companies licensed by New York State, it appears that they will be able to begin selling cannabis extracts...
ALBANY— With roughly three months left until the state’s medical marijuana program is supposed to be fully operational, several companies awarded a license to grow and distribute the drug...
Photo credit: Mia Di Stefano On a recent Thursday evening in downtown Manhattan, nearly 50 women and a few men, ranging from millennials to baby boomers, gathered in a...
